Dariela Cardo
Optometrist · Philadelphia, PANPI 1497433742
Payments from drug & device makers
Across 70 payments — averaging $71.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Coopervision Inc.$929
- Bausch & Lomb Americas Inc.$700
- Glaukos Corporation$430
- AbbVie$238
- Johnson & Johnson Vision Care, Inc.$179
- plus $602 from 10 others
What the payments were for
- Consulting fees$55011%
- Speaking & faculty fees$1754%
- Travel & lodging$1,04321%
- Food & beverage$2,47050%
- Education$75015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 17 | $1,909 |
| Coopervision Inc. | 4 | $929 |
| Bausch & Lomb Americas Inc. | 18 | $700 |
| Glaukos Corporation | 4 | $430 |
| AbbVie | 9 | $238 |
| Johnson & Johnson Vision Care, Inc. | 3 | $179 |
| Tarsus Pharmaceuticals, Inc. | 3 | $151 |
| Oyster Point Pharma, Inc. | 2 | $135 |
| Visionary Optics LLC | 1 | $106 |
| Mallinckrodt Hospital Products Inc. | 1 | $37 |
| ANI Pharmaceuticals, Inc. | 2 | $37 |
| Dompe US, Inc. | 1 | $31 |
| Rayner Intraocular Lenses Limited | 1 | $31 |
| Biotissue Holdings Inc. | 2 | $30 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Harrow Eye, LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SynergEyes contact lens$750
- CE-marked KXLA system$339
- AIR OPTIX$175
- Rocklatan$141
- INFUSE$137
- TYRVAYA$117
- Clariti Contact Lens$113
- Acuvue$113
- VYZULTA$112
- MIEBO$103
How this compares
$4,987 in reported general payments places this provider in the 90th percentile of 2,165 optometrist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 105 | $3,138 |
| Ketorolac Tromethamine | 91 | $1,010 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 21 | $421 |
| Brimonidine Tartrate | 13 | $379 |
| Latanoprost | 31 | $180 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Philadelphia
- Shivakhaami MeiyeppenPhiladelphia$100K
- Gretchen BrewerPhiladelphia$79K
- Alan KabatPhiladelphia$49K
- Melissa TregoPhiladelphia$46K
- Elizabeth TonkeryPhiladelphia$40K
- Clark ChangPhiladelphia$37K
- Tu DinhPhiladelphia$28K
- Justin ShermanPhiladelphia$17K
- Diana ChuongPhiladelphia$10K
- David DuffyPhiladelphia$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.